Cryptosporidium pathogenicity and virulence

Clinical Microbiology Reviews

Volumn 26, Issue 1, 2013, Pages 115-134

  Bouzid, Maha ^a   Hunter, Paul R ^a   Chalmers, Rachel M ^b   Tyler, Kevin M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b SINGLETON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; CARBAMOYL PHOSPHATE SYNTHASE; CYSTEINE PROTEINASE; GLYCOPROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEMOLYSIN; HOST FACTOR; PROTEIN P23; PROTEIN P30; SECRETORY PHOSPHOLIPASE A2; SERINE PROTEINASE; SMALL INTERFERING RNA; THROMBOSPONDIN; VIRULENCE FACTOR;

ARTICLE; CELL ADHESION; CELL DAMAGE; COEVOLUTION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROENTERITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PARASITOLOGY IMMUNOFLUORESCENCE ASSAY; POLYMERASE CHAIN REACTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TROPISM;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; GASTROENTERITIS; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRULENCE; VIRULENCE FACTORS;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; PROTOZOA; VERTEBRATA;

EID: 84872178760     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00076-12     Document Type: Article

References (277)

1. Isenberg HD. 1988. Pathogenicity and virulence: another view. Clin. Microbiol. Rev. 1:40-53.
2. Alonso-Monge R, Navarro-García F, Román E, Eisman B, Nombela C, Pla J. 2003. Strategies for the identification of virulence determinants in human pathogenic fungi. Curr. Genet. 42:301-312.
3. Bloch H. 1950. A component of tubercle bacilli concerned with their virulence. Bull. N. Y. Acad. Med. 26:506-507.
4. Ebert D, Herre EA. 1996. The evolution of parasitic diseases. Parasitol. Today 12:96-101.
5. Garnick E. 1992. Parasite virulence and parasite-host coevolution: a reappraisal. J. Parasitol. 78:381-386.
6. Mellon R. 1926. Studies in microbic heredity. VIII. The infectivity and virulence of a filtrable phase in the life history of B. fusiformis and related organisms. J. Bacteriol. 12:279-298.
7. Pike R, Mackenzie GM. 1940. Virulence of Salmonella typhimurium. I. Analysis of experimental infection in mice with strains of high and low virulence. J. Bacteriol. 40:171-195.
8. Poulin R, Combes C. 1999. The concept of virulence: interpretations and implications. Parasitol. Today 15:474-475.
9. Smiley H, Pearse H. 1926. Determining the virulence of positive diphtheria cultures. Am. J. Public Health (N. Y.) 16:998-1002.
10. Woolhouse ME, Webster JP, Domingo E, Charlesworth B, Levin BR. 2002. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 32:569-577.
11. Casadevall A, Pirofski L. 2001. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184:337-344.
12. Casadevall A, Pirofski LA. 1999. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67: 3703-3713.
13. Okhuysen PC, Chappell CL. 2002. Cryptosporidium virulence determinants- are we there yet? Int. J. Parasitol. 32:517-525.
14. Fayer R, Orlandi P, Perdue ML. 2009. Virulence factor activity relationships for hepatitis E and Cryptosporidium. J. Water Health 7(Suppl 1): S55-S63. doi:10.2166/wh.2009.044.
15. Navarro-Garcia F, Sanchez M, Nombela C, Pla J. 2001. Virulence genes in the pathogenic yeast Candida albicans. FEMS Microbiol. Rev. 25:245-268.
16. Edberg SC. 2009. Does the possession of virulence factor genes mean that those genes will be active? J. Water Health 7(Suppl 1):S19-S28. doi: 10.2166/wh.2009.066.
17. Karger A, Ziller M, Bettin B, Mintel B, Schares S, Geue L. 2011. Determination of serotypes of Shiga toxin-producing Escherichia coli isolates by intact cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl. Environ. Microbiol. 77:896-905.
18. van Asten AJ, van Dijk JE. 2005. Distribution of "classic" virulence factors among Salmonella spp. FEMS Immunol. Med. Microbiol. 44: 251-259.
19. Verstrepen KJ, Fink GR. 2009. Genetic and epigenetic mechanisms underlying cell-surface variability in protozoa and fungi. Annu. Rev. Genet. 43:1-24.
20. Goldston AM, Powell RR, Temesvari LA. 2012. Sink or swim: lipid rafts in parasite pathogenesis. Trends Parasitol. 28:417-426.
21. Butler CE, Tyler KM. 2012. Membrane traffic and synaptic cross-talk during host cell entry by Trypanosoma cruzi. Cell. Microbiol. 14:1345-1353.
22. Schmid-Hempel P. 2008. Parasite immune evasion: a momentous molecular war. Trends Ecol. Evol. 23:318-326.
23. Sibley LD. 2011. Invasion and intracellular survival by protozoan parasites. Immunol. Rev. 240:72-91.
24. Landfear SM. 2011. Nutrient transport and pathogenesis in selected parasitic protozoa. Eukaryot. Cell 10:483-493.
25. McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M. 2006. Proteases in parasitic diseases. Annu. Rev. Pathol. 1:497-536.
26. Ashton AW, Mukherjee S, Nagajyothi FNU, Huang H, Braunstein VL, Desruisseaux MS, Factor SM, Lopez L, Berman JW, Wittner M, Scherer PE, Capra V, Coffman TM, Serhan CN, Gotlinger K, Wu KK, Weiss LM, Tanowitz HB. 2007. Thromboxane A(2) is a key regulator of pathogenesis during Trypanosoma cruzi infection. J. Exp. Med. 204: 929-940.
27. Dean S, Marchetti R, Kirk K, Matthews KR. 2009. A surface transporter family conveys the trypanosome differentiation signal. Nature 459:213-217.
28. McClelland E, Bernhardt P, Casadevall A. 2006. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect. Immun. 74:1500-1504.
29. Tyzzer EE. 1907. A sporozoan found in the peptic glands of the common mouse. Proc. Soc. Exp. Biol. Med. 5:12-13.
30. Tyzzer EE. 1912. Cryptosporidium parvum (sp. nov.), a coccidium found in the small intestine of the common mouse. Arch. Protistenkd. 26:394-412.
31. Slavin D. 1955. Cryptosporidium meleagridis (sp. nov.). J. Comp. Pathol. 65:262-266.
32. Panciera RJ, Thomassen RW, Gardner FM. 1971. Cryptosporidial infection in a calf. Vet. Pathol. 8:479-484.
33. Current W, Garcia LS. 1991. Cryptosporidiosis. Clin. Microbiol. Rev. 4:325-358.
34. De Graaf D, Vanopdenbosch E, Ortega-Mora LM, Abbassi H, Peeters JE. 1999. A review of the importance of cryptosporidiosis in farm animals. Int. J. Parasitol. 29:1269-1287.
35. Holland R. 1990. Some infectious causes of diarrhea in young farm animals. Clin. Microbiol. Rev. 3:345-375.
36. Meuten D, Van Kruiningen HJ, Lein DH. 1974. Cryptosporidiosis in a calf. J. Am. Vet. Med. Assoc. 165:914-917.
37. Moore AC, Herwaldt BL, Craun GF, Calderon RL, Highsmith AK, Juranek DD. 1993. Surveillance for waterborne disease outbreaks- United States, 1991-1992. MMWR CDC Surveill. Summ. 42:1-22.
38. O'Handley R, Olson ME. 2006. Giardiasis and cryptosporidiosis in ruminants. Vet. Clin. North Am. Food Anim. Pract. 22:623-643.
39. Tzipori S, Campbell I, Sherwood D, Snodgrass DR, Whitelaw A. 1980. An outbreak of calf diarrhoea attributed to cryptosporidial infection. Vet. Rec. 107:579-580.
40. Blagburn B, Lindsay DS, Giambrone JJ, Sundermann CA, Hoerr FJ. 1987. Experimental cryptosporidiosis in broiler chickens. Poult. Sci. 66: 442-449.
41. Current W, Snyder DB. 1988. Development of and serologic evaluation of acquired immunity to Cryptosporidium baileyi by broiler chickens. Poult. Sci. 67:720-729.
42. Goodwin M. 1989. Cryptosporidiosis in birds-a review. Avian Pathol. 18:365-384.
43. O'Donoghue P. 1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:139-195.
44. Meisel J, Perera DR, Meligro C, Rubin CE. 1976. Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology 70:1156-1160.
45. Nime F, Burek JD, Page DL, Holscher MA, Yardley JH. 1976. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology 70:592-598.
46. Crawford F, Vermund SH. 1988. Human cryptosporidiosis. Crit. Rev. Microbiol. 16:113-159.
47. Current W, Reese NC, Ernst JV, Bailey WS, Heyman MB, Weinstein WM. 1983. Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N. Engl. J. Med. 308:1252-1257.
48. Fayer R, Ungar BL. 1986. Cryptosporidium spp. and cryptosporidiosis. Microbiol. Rev. 50:458-483.
49. Forgacs P, Tarshis A, Ma P, Federman M, Mele L, Silverman ML, Shea JA. 1983. Intestinal and bronchial cryptosporidiosis in an immunodeficient homosexual man. Ann. Intern. Med. 99:793-794.
50. Ma P, Soave R. 1983. Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea. J. Infect. Dis. 147:824-828.
51. Soave R, Danner RL, Honig CL, Ma P, Hart CC, Nash T, Roberts RB. 1984. Cryptosporidiosis in homosexual men. Ann. Intern. Med. 100: 504-511.
52. Jokipii L, Pohjola S, Jokipii AM. 1983. Cryptosporidium: a frequent finding in patients with gastrointestinal symptoms. Lancet ii:358-361.
53. Tzipori S, Smith M, Birch C, Barnes G, Bishop R. 1983. Cryptosporidiosis in hospital patients with gastroenteritis. Am. J. Trop. Med. Hyg. 32:931-934.
54. Karanis P, Kourenti C, Smith H. 2007. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J. Water Health 5:1-38.
55. Meinhardt P, Casemore DP, Miller KB. 1996. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol. Rev. 18:118-136.
56. Blackburn BG, Craun GF, Yoder JS, Hill V, Calderon RL, Chen N, Lee SH, Levy DA, Beach MJ. 2004. Surveillance for waterborne-disease outbreaks associated with drinking water-United States, 2001-2002. MMWR Surveill. Summ. 53:23-45.
57. Chen X, Keithly JS, Paya CV, LaRusso NF. 2002. Cryptosporidiosis. N. Engl. J. Med. 346:1723-1731.
58. Juranek D. 1995. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin. Infect. Dis. 22:S57-S61. doi:10.1093/clinids/21.Supplement_1.S57.
59. Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC, Chaisson RE, Sears CL. 1998. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin. Infect. Dis. 27:536-542.
60. Hunter P, Nichols G. 2002. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev. 15:145-154.
61. Chalmers RM, Davies AP. 2010. Clinical cryptosporidiosis. Exp. Parasitol. 124:138-146.
62. Cacciò S. 2005. Molecular epidemiology of human cryptosporidiosis. Parassitologia 47:185-192.
63. Bouzid M, Tyler KM, Christen R, Chalmers RM, Elwin K, Hunter PR. 2010. Multi-locus analysis of human infective Cryptosporidium species and subtypes using ten novel genetic loci. BMC Microbiol. 10:213. doi: 10.1186/1471-2180-10-213.
64. Chalmers RM, Smith R, Elwin K, Clifton-Hadley FA, Giles M. 2011. Epidemiology of anthroponotic and zoonotic human cryptosporidiosis in England and Wales, 2004-2006. Epidemiol. Infect. 139:700-712.
65. Cama VA, Ross JM, Crawford S, Kawai V, Chavez-Valdez R, Vargas D, Vivar A, Ticona E, Navincopa M, Williamson J, Ortega Y, Gilman RH, Bern C, Xiao L. 2007. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J. Infect. Dis. 196:684-691.
66. Cama VA, Bern C, Roberts J, Cabrera L, Sterling CR, Ortega Y, Gilman RH, Xiao L. 2008. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg. Infect. Dis. 14:1567-1574.
67. Hunter P, Hughes S, Woodhouse S, Raj N, Syed Q, Chalmers RM, Verlander NQ, Goodacre J. 2004. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin. Infect. Dis. 39:504-510.
68. Casemore D, Sands RL, Curry A. 1985. Cryptosporidium species a "new" human pathogen. J. Clin. Pathol. 38:1321-1336.
69. Hunter P, Thompson RC. 2005. The zoonotic transmission of Giardia and Cryptosporidium. Int. J. Parasitol. 35:1181-1190.
70. Xiao L, Feng Y. 2008. Zoonotic cryptosporidiosis. FEMS Immunol. Med. Microbiol. 52:309-323.
71. Glaberman S, Moore JE, Lowery CJ, Chalmers RM, Sulaiman I, Elwin K, Rooney PJ, Millar BC, Dooley JS, Lal AA, Xiao L. 2002. Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg. Infect. Dis. 8:631-633.
72. Guerrant R. 1997. Cryptosporidiosis: an emerging, highly infectious threat. Emerg. Infect. Dis. 3:51-57.
73. Hayes EB, Matte TD, O'Brien TR, McKinley TW, Logsdon GS, Rose JB, Ungar BLP, Word DM, Wilson MA, Long EG, Hurwitz ES, Juranek DD. 1989. Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N. Engl. J. Med. 320:1372-1376.
74. Jiang J, Alderisio KA, Xiao L. 2005. Distribution of Cryptosporidium genotypes in storm event water samples from three watersheds in New York. Appl. Environ. Microbiol. 71:4446-4454.
75. Xiao L, Alderisio K, Limor J, Royer M, Lal AA. 2000. Identification of species and sources of Cryptosporidium oocysts in storm waters with a small-subunit rRNA-based diagnostic and genotyping tool. Appl. Environ. Microbiol. 66:5492-5498.
76. Egger M, Mäusezahl D, Odermatt P, Marti HP, Tanner M. 1990. Symptoms and transmission of intestinal cryptosporidiosis. Arch. Dis. Child. 65:445-447.
77. Harari M, West B, Dwyer B. 1986. Cryptosporidium as cause of laryngotracheitis in an infant. Lancet i:1207. doi:10.1016/S0140 -6736(86)91181-5.
78. Ma P, Villanueva TG, Kaufman D, Gillooley JF. 1984. Respiratory cryptosporidiosis in the acquired immune deficiency syndrome. Use of modified cold kinyoun and hemacolor stains for rapid diagnoses. JAMA 252:1298-1301.
79. Tzipori S, Ward H. 2002. Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect. 4:1047-1058.
80. Goldstein ST, Juranek DD, Ravenholt O, Hightower AW, Martin DG, Mesnik JL, Griffiths SD, Bryant AJ, Reich RR, Herwaldt BL. 1996. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann. Intern. Med. 124:459-468.
81. Kramer MH, Sorhage FE, Goldstein ST, Dalley E, Wahlquist SP, Herwaldt BL. 1998. First reported outbreak in the United States of cryptosporidiosis associated with a recreational lake. Clin. Infect. Dis. 26:27-33.
82. MacKenzie WR, Schell WL, Blair KA, Addiss DG, Peterson DE, Hoxie NJ, Kazmierczak JJ, Davis JP. 1995. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin-recurrence of illness and risk of secondary transmission. Clin. Infect. Dis. 21:57-62.
83. McAnulty JM, Fleming DW, Gonzalez AH. 1994. A community-wide outbreak of cryptosporidiosis associated with swimming at a wave pool. JAMA 272:1597-1600.
84. Yoder JS, Beach MJ. 2010. Cryptosporidium surveillance and risk factors in the United States. Exp. Parasitol. 124:31-39.
85. Robertson B, Sinclair MI, Forbes AB, Veitch M, Kirk M, Cunliffe D, Willis J, Fairley CK. 2002. Case-control studies of sporadic cryptosporidiosis in Melbourne and Adelaide, Australia. Epidemiol. Infect. 128: 419-431.
86. Roy S, DeLong SM, Stenzel SA, Shiferaw B, Roberts JM, Khalakdina A, Marcus R, Segler SD, Shah DD, Thomas S, Vugia DJ, Zansky SM, Dietz V, Beach MJ, Emerging Infections Program FoodNet Working Group. 2004. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. J. Clin. Microbiol. 42:2944-2951.
87. Goh S, Reacher M, Casemore DP, Verlander NQ, Chalmers R, Knowles M, Williams J, Osborn K, Richards S. 2004. Sporadic cryptosporidiosis, North Cumbria, England, 1996-2000. Emerg. Infect. Dis. 10:1007-1015.
88. Pintar KD, Pollari F, Waltner-Toews D, Charron DF, McEwen SA, Fazil A, Nesbitt A. 2009. A modified case-control study of cryptosporidiosis (using non-Cryptosporidium-infected enteric cases as controls) in a community setting. Epidemiol. Infect. 137:1789-1799.
89. Valderrama AL, Hlavsa MC, Cronquist A, Cosgrove S, Johnston SP, Roberts JM, Stock ML, Xiao L, Xavier K, Beach MJ. 2009. Multiple risk factors associated with a large statewide increase in cryptosporidiosis. Epidemiol. Infect. 137:1781-1788.
90. Frost FJ, Roberts M, Kunde TR, Craun G, Tollestrup K, Harter L, Muller T. 2005. How clean must our drinking water be: the importance of protective immunity. J. Infect. Dis. 191:809-814.
91. Colford JM, Jr, Saha SR, Wade TJ, Wright CC, Vu M, Charles S, Jensen P, Hubbard A, Levy DA, Eisenberg JN. 2005. A pilot randomized, controlled trial of an in-home drinking water intervention among HIV+ persons. J. Water Health 3:173-184.
92. Dwivedi KK, Prasad G, Saini S, Mahajan S, Lal S, Baveja UK. 2007. Enteric opportunistic parasites among HIV infected individuals: associated risk factors and immune status. Jpn. J. Infect. Dis. 60:76-81.
93. Hellard M, Hocking J, Willis J, Dore G, Fairley C. 2003. Risk factors leading to Cryptosporidium infection in men who have sex with men. Sex. Transm. Infect. 79:412-414.
94. Becher KA, Robertson ID, Fraser DM, Palmer DG, Thompson RC. 2004. Molecular epidemiology of Giardia and Cryptosporidium infections in dairy calves originating from three sources in Western Australia. Vet. Parasitol. 123:1-9.
95. Horman A, Korpela H, Sutinen J, Wedel H, Hanninen ML. 2004. Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries. Int. J. Parasitol. 34:1337-1346.
96. Nimri L, Batchoun R. 1994. Prevalence of Cryptosporidium species in elementary school children. J. Clin. Microbiol. 32:1040-1042.
97. Okafor JI, Okunji PO. 1996. Prevalence of Cryptosporidium oocysts in faecal samples of some school children in Enugu State, Nigeria. J. Commun. Dis. 28:49-55.
98. Wallis PM, Erlandsen SL, Isaac-Renton JL, Olson ME, Robertson WJ, van Keulen H. 1996. Prevalence of Giardia cysts and Cryptosporidium oocysts and characterization of Giardia spp. isolated from drinking water in Canada. Appl. Environ. Microbiol. 62:2789-2797.
99. Blanco MA, Iborra A, Vargas A, Nsie E, Mba L, Fuentes I. 2009. Molecular characterization of Cryptosporidium isolates from humans in Equatorial Guinea. Trans. R. Soc. Trop. Med. Hyg. 103:1282-1284.
100. Leoni F, Amar C, Nichols G, Pedraza-Díaz S, McLauchlin J. 2006. Genetic analysis of Cryptosporidium from 2414 humans with diarrhoea in England between 1985 and 2000. J. Med. Microbiol. 55:703-707.
101. Mueller-Doblies D, Giles M, Elwin K, Smith RP, Clifton-Hadley FA, Chalmers RM. 2008. Distribution of Cryptosporidium species in sheep in the UK. Vet. Parasitol. 154:214-219.
102. Brook EJ, Anthony Hart C, French NP, Christley RM. 2009. Molecular epidemiology of Cryptosporidium subtypes in cattle in England. Vet. J. 179:378-382.
103. Chalmers R, Hadfield SJ, Jackson CJ, Elwin K, Xiao L, Hunter P. 2008. Geographic linkage and variation in Cryptosporidium hominis. Emerg. Infect. Dis. 14:496-498.
104. Geurden T, Levecke B, Caccio SM, Visser A, De Groote G, Casaert S, Vercruysse J, Claerebout E. 2009. Multilocus genotyping of Cryptospo-ridium and Giardia in non-outbreak related cases of diarrhoea in human patients in Belgium. Parasitology 136:1161-1168.
105. Hunter P, Hadfield SJ, Wilkinson D, Lake IR, Harrison FC, Chalmers RM. 2007. Subtypes of Cryptosporidium parvum in humans and disease risk. Emerg. Infect. Dis. 13:82-88.
106. Xiao L, Hlavsa MC, Yoder J, Ewers C, Dearen T, Yang W, Nett R, Harris S, Brend SM, Harris M, Onischuk L, Valderrama AL, Cosgrove S, Xavier K, Hall N, Romero S, Young S, Johnston SP, Arrowood M, Roy S, Beach MJ. 2009. Subtype analysis of Cryptosporidium specimens from sporadic cases in Colorado, Idaho, New Mexico, and Iowa in 2007: widespread occurrence of one Cryptosporidium hominis subtype and case history of an infection with the Cryptosporidium horse genotype. J. Clin. Microbiol. 47:3017-3020.
107. Zintl A, Proctor AF, Read C, Dewaal T, Shanaghy N, Fanning S, Mulcahy G. 2009. The prevalence of Cryptosporidium species and subtypes in human faecal samples in Ireland. Epidemiol. Infect. 137:270-277.
108. Alves M, Xiao L, Antunes F, Matos O. 2006. Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal. Parasitol. Res. 99:287-292.
109. Leav B, Mackay MR, Anyanwu A, O'Connor RM, Cevallos AM, Kindra G, Rollins NC, Bennish ML, Nelson RG, Ward HD. 2002. Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa. Infect. Immun. 70:3881-3890.
110. Fayer R, Morgan U, Upton SJ. 2000. Epidemiology of Cryptosporidium: transmission, detection and identification. Int. J. Parasitol. 30: 1305-1322.
111. Ramirez N, Ward LA, Sreevatsan S. 2004. A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes Infect. 6:773-785.
112. Tzipori S, Widmer G. 2008. A hundred-year retrospective on cryptosporidiosis. Trends Parasitol. 24:184-189.
113. Xiao L, Fayer R. 2008. Molecular characterisation of species and genotypes of Cryptosporidium and Giardia and assessment of zoonotic transmission. Int. J. Parasitol. 38:1239-1255.
114. Xiao L. 2010. Molecular epidemiology of cryptosporidiosis: an update. Exp. Parasitol. 124:80-89.
115. Jex AR, Smith HV, Monis PT, Campbell BE, Gasser RB. 2008. Cryptosporidium- biotechnological advances in the detection, diagnosis and analysis of genetic variation. Biotechnol. Adv. 26:304-317.
116. Chalmers RM, Campbell B, Crouch N, Davies AP. 2010. Clinical laboratory practices for detection and reporting of Cryptosporidium in community cases of diarrhoea in the United Kingdom, 2008. Euro Surveill. 15(48):pii=_19731. http://www.eurosurveillance.org /ViewArticle.aspx?ArticleId_19731.
117. Bouzid M, Steverding D, Tyler KM. 2008. Detection and surveillance of waterborne protozoan parasites. Curr. Opin. Biotechnol. 19:302-306.
118. Bruijnesteijn van Coppenraet LES, Wallinga JA, Ruijs GJHM, Bruins MJ, Verweij JJ. 2009. Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopy. Clin. Microbiol. Infect. 15:869-874.
119. Laxer MA, Timblin BK, Patel RJ. 1991. DNA sequences for the specific detection of Cryptosporidium parvum by the polymerase chain reaction. Am. J. Trop. Med. Hyg. 45:688-694.
120. Amar CFL, East CL, Gray J, Iturriza-Gomara M, Maclure EA, McLauchlin J. 2007. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur. J. Clin. Microbiol. Infect. Dis. 26:311-323.
121. Chalmers RM, Campbell BM, Crouch N, Charlett A, Davies AP. 2011. Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J. Med. Microbiol. 60:1598-1604.
122. Davies AP, Chalmers RM. 2009. Cryptosporidiosis. BMJ 339:b4168. doi:10.1136/bmj.b4168.
123. Widmer G, Sullivan S. 2012. Genomics and population biology of Cryptosporidium species. Parasite Immunol. 34:61-71.
124. Robinson G, Chalmers RM. 2012. Assessment of polymorphic genetic markers for multi-locus typing of Cryptosporidium parvum and Cryptosporidium hominis. Exp. Parasitol. 132:200-215.
125. Barta JR, Thompson RC. 2006. What is Cryptosporidium? Reappraising its biology and phylogenetic affinities. Trends Parasitol. 22:463-468.
126. Thompson RC, Olson ME, Zhu G, Enomoto S, Abrahamsen MS, Hijjawi NS. 2005. Cryptosporidium and cryptosporidiosis. Adv. Parasitol. 59:77-158.
127. Rosales MJ, Cordon GP, Moreno MS, Sanchez CM. 2005. Extracellular like-gregarine stages of Cryptosporidium parvum. Acta Trop. 95:74-78.
128. Fayer R, Leek RG. 1984. The effects of reducing conditions, medium, pH, temperature, and time on in vitro excystation of Cryptosporidium. J. Protozool. 31:567-569.
129. Reduker D, Speer CA. 1985. Factors influencing excystation in Cryptosporidium oocysts from cattle. J. Parasitol. 71:112-115.
130. Robertson L, Campbell AT, Smith HV. 1993. In vitro excystation of Cryptosporidium parvum. Parasitology 106:13-19.
131. Wetzel DM, Schmidt J, Kuhlenschmidt MS, Dubey JP, Sibley LD. 2005. Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites. Infect. Immun. 73:5379-5387.
132. Chen XM, O'Hara SP, Huang BQ, Nelson JB, Lin JJ, Zhu G, Ward HD, LaRusso NF. 2004. Apical organelle discharge by Cryptosporidium parvum is temperature, cytoskeleton, and intracellular calcium dependent and required for host cell invasion. Infect. Immun. 72:6806-6816.
133. Wanyiri J, Ward H. 2006. Molecular basis of Cryptosporidium-host cell interactions: recent advances and future prospects. Future Microbiol. 1:201-208.
134. Tetley L, Brown SM, McDonald V, Coombs GH. 1998. Ultrastructural analysis of the sporozoite of Cryptosporidium parvum. Microbiology 144(Part 12):3249-3255.
135. Boulter-Bitzer J, Lee H, Trevors JT. 2007. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Biotechnol. Adv. 25:13-44.
136. Bonnin A, Dubremetz JF, Camerlynck P. 1993. A new antigen of Cryptosporidium parvum micronemes possessing epitopes crossreactive with macrogamete granules. Parasitol. Res. 79:8-14.
137. Petersen C, Gut J, Doyle PS, Crabb JH, Nelson RG, Leech JH. 1992. Characterization of a _900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin. Infect. Immun. 60:5132-5138.
138. Tomley FM, Soldati DS. 2001. Mix and match modules: structure and function of microneme proteins in apicomplexan parasites. Trends Parasitol. 17:81-88.
139. Göbel E, Brändler U. 1982. Ultrastructure of microgametogenesis, microgametes and gametogony of Cryptosporidium sp. in the small intestine of mice. Protistologica 18:331-344.
140. Smith H, Rose JB. 1998. Waterborne cryptosporidiosis: current status. Parasitol. Today 14:14-22.
141. Current W, Reese NC. 1986. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J. Protozool. 33: 98-108.
142. Siński E, Behnke JM. 2004. Apicomplexan parasites: environmental contamination and transmission. Pol. J. Microbiol. 53:67-73.
143. DuPont H, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. 1995. The infectivity of Cryptosporidium parvum in healthy volunteers. N. Engl. J. Med. 332:855-859.
144. Jokipii L, Jokipii AM. 1986. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N. Engl. J. Med. 315:1643-1647.
145. Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL. 1999. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180:1275-1281.
146. Blunt D, Khramtsov NV, Upton SJ, Montelone BA. 1997. Molecular karyotype analysis of Cryptosporidium parvum: evidence for eight chromosomes and a low-molecular-size molecule. Clin. Diagn. Lab. Immunol. 4:11-13.
147. Hays M, Mosier DA, Oberst RD. 1995. Enhanced karyotype resolution of Cryptosporidium parvum by contour-clamped homogeneous electric fields. Vet. Parasitol. 58:273-280.
148. Khramtsov N, Woods KM, Nesterenko MV, Dykstra CC, Upton SJ. 1997. Virus-like, double-stranded RNAs in the parasitic protozoan Cryptosporidium parvum. Mol. Microbiol. 26:289-300.
149. Clark D. 1999. New insights into human cryptosporidiosis. Clin. Microbiol. Rev. 12:554-563.
150. Le Blancq S, Khramtsov NV, Zamani F, Upton SJ, Wu TW. 1997. Ribosomal RNA gene organization in Cryptosporidium parvum. Mol. Biochem. Parasitol. 90:463-478.
151. LaGier M, Tachezy J, Stejskal F, Kutisova K, Keithly JS. 2003. Mitochondrial- type iron-sulfur cluster biosynthesis genes (IscS and IscU) in the apicomplexan Cryptosporidium parvum. Microbiology 149:3519-3530.
152. Zhu G, Marchewka MJ, Keithly JS. 2000. Cryptosporidium parvum appears to lack a plastid genome. Microbiology 146:315-321.
153. Abrahamsen M, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, Lancto CA, Deng M, Liu C, Widmer G, Tzipori S, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, Aravind L, Kapur V. 2004. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 304:441-445.
154. Xu P, Widmer G, Wang Y, Ozaki LS, Alves JM, Serrano MG, Puiu D, Manque P, Akiyoshi D, Mackey AJ, Pearson WR, Dear PH, Bankier AT, Peterson DL, Abrahamsen MS, Kapur V, Tzipori S, Buck GA. 2004. The genome of Cryptosporidium hominis. Nature 431:1107-1112.
155. Widmer G, Carlton JM, Silva JC, London E. 2007. The Cryptosporidium muris genome project: a progress report, abstr 114. Abstr. 2nd Int. Giardia Cryptosporidium Conf., Morelia, Michoacan, Mexico, 13 to 18 May 2007.
156. Rider SD, Jr, Zhu G. 2010. Cryptosporidium: genomic and biochemical features. Exp. Parasitol. 124:2-9.
157. Pain A, Crossman L, Parkhill J. 2005. Comparative apicomplexan genomics. Nat. Rev. Microbiol. 3:454-455.
158. Keithly J, Langreth SG, Buttle KF, Mannella CA. 2005. Electron tomographic and ultrastructural analysis of the Cryptosporidium parvum relict mitochondrion, its associated membranes, and organelles. J. Eukaryot. Microbiol. 52:132-140.
159. Puiu D, Enomoto S, Buck GA, Abrahamsen MS, Kissinger JC. 2004. CryptoDB: the Cryptosporidium genome resource. Nucleic Acids Res. 32:D329-D331. doi:10.1093/nar/gkh050.
160. Striepen B, Kissinger JC. 2004. Genomics meets transgenics in search of the elusive Cryptosporidium drug target. Trends Parasitol. 20:355-358.
161. Templeton T, Iyer LM, Anantharaman V, Enomoto S, Abrahante JE, Subramanian GM, Hoffman SL, Abrahamsen MS, Aravind L. 2004. Comparative analysis of apicomplexa and genomic diversity in eukaryotes. Genome Res. 14:1686-1695.
162. Gordon JL, Sibley LD. 2005. Comparative genome analysis reveals a conserved family of actin-like proteins in apicomplexan parasites. BMC Genomics 6:179. doi:10.1186/1471-2164-6-179.
163. Nagamune K, Sibley LD. 2006. Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa. Mol. Biol. Evol. 23:1613-1627.
164. Kuo C, Wares JP, Kissinger JC. 2008. The apicomplexan whole-genome phylogeny: an analysis of incongruence among gene trees. Mol. Biol. Evol. 25:2689-2698.
165. Bouzid M, Hunter PR, McDonald V, Elwin K, Chalmers RM, Tyler KM. 2012. A new heterogeneous family of telomerically encoded Cryptosporidium proteins. Evol. Appl. doi:10.1111/j.1752-4571.2012.00277.x.
166. Widmer G, Lee Y, Hunt P, Martinelli A, Tolkoff M, Bodi K. 2012. Comparative genome analysis of two Cryptosporidium parvum isolates with different host range. Infect. Genet. Evol. 12:1213-1221.
167. Snelling WJ, Lin Q, Moore JE, Millar BC, Tosini F, Pozio E, Dooley JS, Lowery CJ. 2007. Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa). Mol. Cell. Proteomics 6:346-355.
168. Artz JD, Wernimont AK, Allali-Hassani A, Zhao Y, Amani M, Lin YH, Senisterra G, Wasney GA, Fedorov O, King O, Roos A, Lunin VV, Qiu W, Finerty P, Jr, Hutchinson A, Chau I, von Delft F, Mackenzie F, Lew J, Kozieradzki I, Vedadi M, Schapira M, Zhang C, Shokat K, Heightman T, Hui R. 2011. The Cryptosporidium parvum kinome. BMC Genomics 12:478. doi:10.1186/1471-2164-12-478.
169. Okhuysen PC, Chappell CL, Kettner C, Sterling CR. 1996. Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation. Antimicrob. Agents Chemother. 40:2781-2784.
170. Riggs MW, Stone AL, Yount PA, Langer RC, Arrowood MJ, Bentley DL. 1997. Protective monoclonal antibody defines a circumsporozoitelike glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol. 158:1787-1795.
171. Strong W, Gut J, Nelson RG. 2000. Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60- kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products. Infect. Immun. 68:4117-4134.
172. Cevallos A, Zhang X, Waldor MK, Jaison S, Zhou X, Tzipori S, Neutra MR, Ward HD. 2000. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect. Immun. 68:4108-4116.
173. Cevallos AM, Bhat N, Verdon R, Hamer DH, Stein B, Tzipori S, Pereira ME, Keusch GT, Ward HD. 2000. Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect. Immun. 68:5167-5175.
174. Perryman LE, Jasmer DP, Riggs MW, Bohnet SG, McGuire TC, Arrowood MJ. 1996. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol. Biochem. Parasitol. 80: 137-147.
175. Arrowood MJ, Sterling CR, Healey MC. 1991. Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. J. Parasitol. 77:315-317.
176. Bhat N, Joe A, PereiraPerrin M, Ward HD. 2007. Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro. J. Biol. Chem. 282:34877-34887.
177. Spano F, Putignani L, Naitza S, Puri C, Wright S, Crisanti A. 1998. Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. Mol. Biochem. Parasitol. 92:147-162.
178. Nesterenko MV, Woods K, Upton SJ. 1999. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell. Biochim. Biophys. Acta 1454:165-173.
179. Bjorneby JM, Riggs MW, Perryman LE. 1990. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites. J. Immunol. 145:298-304.
180. Riggs MW, McGuire TC, Mason PH, Perryman LE. 1989. Neutralization- sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites. J. Immunol. 143:1340-1345.
181. Tosini F, Agnoli A, Mele R, Gomez Morales MA, Pozio E. 2004. A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol. Biochem. Parasitol. 134:137-147.
182. Pollok RC, McDonald V, Kelly P, Farthing MJ. 2003. The role of Cryptosporidium parvum-derived phospholipase in intestinal epithelial cell invasion. Parasitol. Res. 90:181-186.
183. Steele MI, Kuhls TL, Nida K, Meka CS, Halabi IM, Mosier DA, Elliott W, Crawford DL, Greenfield RA. 1995. A Cryptosporidium parvum genomic region encoding hemolytic activity. Infect. Immun. 63:3840-3845.
184. Perkins ME, Riojas YA, Wu TW, Le Blancq SM. 1999. CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the hostparasite boundary in intracellular stages. Proc. Natl. Acad. Sci. U. S. A. 96:5734-5739.
185. LaGier MJ, Zhu G, Keithly JS. 2001. Characterization of a heavy metal ATPase from the apicomplexan Cryptosporidium parvum. Gene 266: 25-34.
186. LaGier MJ, Keithly JS, Zhu G. 2002. Characterisation of a novel transporter from Cryptosporidium parvum. Int. J. Parasitol. 32:877-887.
187. Khramtsov NV, Tilley M, Blunt DS, Montelone BA, Upton SJ. 1995. Cloning and analysis of a Cryptosporidium parvum gene encoding a protein with homology to cytoplasmic form Hsp70. J. Eukaryot. Microbiol. 42:416-422.
188. Zhu G, LaGier MJ, Stejskal F, Millership JJ, Cai X, Keithly JS. 2002. Cryptosporidium parvum: the first protist known to encode a putative polyketide synthase. Gene 298:79-89.
189. Nesterenko MV, Tilley M, Upton SJ. 1995. A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios 83:77-88.
190. Camero L, Shulaw WP, Xiao L. 2003. Characterization of a Cryptosporidium parvum gene encoding a protein with homology to long chain fatty acid synthetase. J. Eukaryot. Microbiol. 50(Suppl):534-538.
191. Wanyiri JW, Techasintana P, O'Connor RM, Blackman MJ, Kim K, Ward HD. 2009. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro. Eukaryot. Cell 8:470-477.
192. Putignani L, Possenti A, Cherchi S, Pozio E, Crisanti A, Spano F. 2008. The thrombospondin-related protein CpMIC1 (CpTSP8) belongs to the repertoire of micronemal proteins of Cryptosporidium parvum. Mol. Biochem. Parasitol. 157:98-101.
193. O'Connor RM, Burns PB, Ha-Ngoc T, Scarpato K, Khan W, Kang G, Ward H. 2009. Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Cryptosporidium parvum infection in vitro. Eukaryot. Cell 8:461-469.
194. Langer RC, Riggs MW. 1999. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells. Infect. Immun. 67:5282-5291.
195. Schaefer DA, Auerbach-Dixon BA, Riggs MW. 2000. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis. Infect. Immun. 68:2608-2616.
196. Langer RC, Schaefer DA, Riggs MW. 2001. Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL. Infect. Immun. 69:1661-1670.
197. Barnes DA, Bonnin A, Huang JX, Gousset L, Wu J, Gut J, Doyle P, Dubremetz JF, Ward H, Petersen C. 1998. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol. Biochem. Parasitol. 96:93-110.
198. Bonnin A, Ojcius DM, Souque P, Barnes DA, Doyle PS, Gut J, Nelson RG, Petersen C, Dubremetz JF. 2001. Characterization of a monoclonal antibody reacting with antigen-4 domain of gp900 in Cryptosporidium parvum invasive stages. Parasitol. Res. 87:589-592.
199. Petersen C, Barnes DA, Gousset L. 1997. Cryptosporidium parvum GP900, a unique invasion protein. J. Eukaryot. Microbiol. 44:89S-90S. doi:10.1111/j.1550-7408.1997.tb05802.x.
200. Sulaiman I, Lal AA, Xiao L. 2001. A population genetic study of the Cryptosporidium parvum human genotype parasites. J. Eukaryot. Microbiol. 2001(Suppl):24S-27S. doi:10.1111/j.1550-7408.2001.tb00441.x.
201. Alves M, Xiao L, Sulaiman I, Lal AA, Matos O, Antunes F. 2003. Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal. J. Clin. Microbiol. 41:2744-2747.
202. Feltus D, Giddings CW, Schneck BL, Monson T, Warshauer D, McEvoy JM. 2006. Evidence supporting zoonotic transmission of Cryptosporidium spp. in Wisconsin. J. Clin. Microbiol. 44:4303-4308.
203. Mallon M, MacLeod A, Wastling JM, Smith H, Tait A. 2003. Multilocus genotyping of Cryptosporidium parvum type 2: population genetics and sub-structuring. Infect. Genet. Evol. 3:207-218.
204. Peng MM, Matos O, Gatei W, Das P, Stantic-Pavlinic M, Bern C, Sulaiman IM, Glaberman S, Lal AA, Xiao L. 2001. A comparison of Cryptosporidium subgenotypes from several geographic regions. J. Eukaryot. Microbiol. 2001(Suppl):28S-31S. doi:10.1111/j.1550-7408.2001.tb00442.x.
205. Peng MM, Wilson ML, Holland RE, Meshnick SR, Lal AA, Xiao L. 2003. Genetic diversity of Cryptosporidium spp. in cattle in Michigan: implications for understanding the transmission dynamics. Parasitol. Res. 90:175-180.
206. Sulaiman I, Hira PR, Zhou L, Al-Ali FM, Al-Shelahi FA, Shweiki HM, Iqbal J, Khalid N, Xiao L. 2005. Unique endemicity of cryptosporidiosis in children in Kuwait. J. Clin. Microbiol. 43:2805-2809.
207. Thompson H, Dooley JS, Kenny J, McCoy M, Lowery CJ, Moore JE, Xiao L. 2007. Genotypes and subtypes of Cryptosporidium spp. in neonatal calves in Northern Ireland. Parasitol. Res. 100:619-624.
208. Trotz-Williams L, Martin DS, Gatei W, Cama V, Peregrine AS, Martin SW, Nydam DV, Jamieson F, Xiao L. 2006. Genotype and subtype analyses of Cryptosporidium isolates from dairy calves and humans in Ontario. Parasitol. Res. 99:346-352.
209. Widmer G. 2009. Meta-analysis of a polymorphic surface glycoprotein of the parasitic protozoa Cryptosporidium parvum and Cryptosporidium hominis. Epidemiol. Infect. 137:1800-1808.
210. Xiao L, Ryan UM. 2004. Cryptosporidiosis: an update in molecular epidemiology. Curr. Opin. Infect. Dis. 17:483-490.
211. Feng Y, Wang L, Duan L, Gomez-Puerta LA, Zhang L, Zhao X, Hu J, Zhang N, Xiao L. 2012. Extended outbreak of cryptosporidiosis in a pediatric hospital, China. Emerg. Infect. Dis. 18:312-314.
212. O'Connor R, Wanyiri JW, Wojczyk BS, Kim K, Ward H. 2007. Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii. Mol. Biochem. Parasitol. 152:149-158.
213. Power ML, Cheung-Kwok-Sang C, Slade M, Williamson S. 2009. Cryptosporidium fayeri: diversity within the GP60 locus of isolates from different marsupial hosts. Exp. Parasitol. 121:219-223.
214. Priest J, Kwon JP, Arrowood MJ, Lammie PJ. 2000. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol. Biochem. Parasitol. 106:261-271.
215. Sestak K, Ward LA, Sheoran A, Feng X, Akiyoshi DE, Ward HD, Tzipori S. 2002. Variability among Cryptosporidium parvum genotype 1 and 2 immunodominant surface glycoproteins. Parasite Immunol. 24: 213-219.
216. Priest JW, Xie LT, Arrowood MJ, Lammie PJ. 2001. The immunodominant 17-kDa antigen from Cryptosporidium parvum is glycosylphosphatidylinositol- anchored. Mol. Biochem. Parasitol. 113:117-126.
217. Gut J, Nelson RG. 1994. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro. J. Eukaryot. Microbiol. 41:42S-43S.
218. Winter G, Gooley AA, Williams KL, Slade MB. 2000. Characterization of a major sporozoite surface glycoprotein of Cryptosporidum parvum. Funct. Integr. Genomics 1:207-217.
219. O'Hara SP, Chen XM. 2011. The cell biology of cryptosporidium infection. Microbes Infect. 13:721-730.
220. Mead JR, Arrowood MJ, Sterling CR. 1988. Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans. J. Parasitol. 74:135-143.
221. Reperant JM, Naciri M, Iochmann S, Tilley M, Bout DT. 1994. Major antigens of Cryptosporidium parvum recognised by serum antibodies from different infected animal species and man. Vet. Parasitol. 55:1-13.
222. Riggs MW, Cama VA, Leary HL, Jr, Sterling CR. 1994. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitatelike reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect. Immun. 62:1927-1939.
223. Tilley M, Eggleston MT, Upton SJ. 1993. Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies. FEMS Microbiol. Lett. 113:235-240.
224. Soldati D, Dubremetz JF, Lebrun M. 2001. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int. J. Parasitol. 31:1293-1302.
225. Adams RB, Guerrant RL, Zu S, Fang G, Roche JK. 1994. Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. J. Infect. Dis. 169:170-177.
226. Que X, Reed SL. 2000. Cysteine proteinases and the pathogenesis of amebiasis. Clin. Microbiol. Rev. 13:196-206.
227. Shenai BR, Sijwali PS, Singh A, Rosenthal PJ. 2000. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 275:29000-29010.
228. Shin MH, Kita H, Park HY, Seoh JY. 2001. Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G. Infect. Immun. 69:1599-1604.
229. Forney JR, Yang S, Du C, Healey MC. 1996. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J. Parasitol. 82:638-640.
230. Miller CM, Akratos C, Johnson AM, Smith NC. 2000. The production of a 70 kDa heat shock protein by Toxoplasma gondii RH strain in immunocompromised mice. Int. J. Parasitol. 30:1467-1473.
231. Woods KM, Tilley M, Iseli A, Upton SJ, Montelone BA, Khramtsov NV. 1999. Sequence of the gene encoding hsp90e from Cryptosporidium parvum. DNA Seq. 10:339-342.
232. Morgan U, Weber R, Xiao L, Sulaiman I, Thompson RC, Ndiritu W, Lal A, Moore A, Deplazes P. 2000. Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virusinfected individuals living in Switzerland, Kenya, and the United States. J. Clin. Microbiol. 38:1180-1183.
233. Sulaiman I, Morgan UM, Thompson RC, Lal AA, Xiao L. 2000. Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl. Environ. Microbiol. 66:2385-2391.
234. Lyons RE, Johnson AM. 1998. Gene sequence and transcription differences in 70 kDa heat shock protein correlate with murine virulence of Toxoplasma gondii. Int. J. Parasitol. 28:1041-1051.
235. Lyons RE, Johnson AM. 1995. Heat shock proteins of Toxoplasma gondii. Parasite Immunol. 17:353-359.
236. Moxon ER, Rainey PB, Nowak MA, Lenski RE. 1994. Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr. Biol. 4:24-33.
237. Deitsch KW, Moxon ER, Wellems TE. 1997. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol. Mol. Biol. Rev. 61:281-293.
238. Henderson IR, Owen P, Nataro JP. 1999. Molecular switches-the ON and OFF of bacterial phase variation. Mol. Microbiol. 33:919-932.
239. Barry JD, Ginger ML, Burton P, McCulloch R. 2003. Why are parasite contingency genes often associated with telomeres? Int. J. Parasitol. 33: 29-45.
240. Yang X, Figueiredo LM, Espinal A, Okubo E, Li B. 2009. RAP1 is essential for silencing telomeric variant surface glycoprotein genes in Trypanosoma brucei. Cell 137:99-109.
241. Kyes S, Horrocks P, Newbold C. 2001. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55:673-707.
242. Kim D, Chiurillo MA, El-Sayed N, Jones K, Santos MR, Porcile PE, Andersson B, Myler P, da Silveira JF, Ramirez JL. 2005. Telomere and subtelomere of Trypanosoma cruzi chromosomes are enriched in (pseudo) genes of retrotransposon hot spot and trans-sialidase-like gene families: the origins of T. cruzi telomeres. Gene 346:153-161.
243. Benfield TL, Lundgren JD. 1998. The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis. FEMS Immunol. Med. Microbiol. 22:129-134.
244. Schmuckli-Maurer J, Casanova C, Schmied S, Affentranger S, Parvanova I, Kang'A S, Nene V, Katzer F, McKeever D, Muller J, Bishop R, Pain A, Dobbelaere DA. 2009. Expression analysis of the Theileria parva subtelomere-encoded variable secreted protein gene family. PLoS One 4:e4839. doi:10.1371/journal.pone.0004839.
245. Widmer G, Tzipori S, Fichtenbaum CJ, Griffiths JK. 1998. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J. Infect. Dis. 178:834-840.
246. Petry F, Jakobi V, Tessema TS. 2010. Host immune response to Cryptosporidium parvum infection. Exp. Parasitol. 126:304-309.
247. Flanigan T, Whalen C, Turner J, Soave R, Toerner J, Havlir D, Kotler D. 1992. Cryptosporidium infection and CD4 counts. Ann. Intern. Med. 116:840-842.
248. Schmidt W, Wahnschaffe U, Schäfer M, Zippel T, Arvand M, Meyerhans A, Riecken EO, Ullrich R. 2001. Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology 120:984-987.
249. Kocoshis SA, Cibull ML, Davis TE, Hinton JT, Seip M, Banwell JG. 1984. Intestinal and pulmonary cryptosporidiosis in an infant with severe combined immune deficiency. J. Pediatr. Gastroenterol. Nutr. 3:149-157.
250. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A. 1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158:977-983.
251. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. 1997. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131:47-54.
252. Wolska-Kusnierz B, Bajer A, Caccio S, Heropolitanska-Pliszka E, Bernatowska E, Socha P, van Dongen J, Bednarska M, Paziewska A, Sinski E. 2007. Cryptosporidium infection in patients with primary immunodeficiencies. J. Pediatr. Gastroenterol. Nutr. 45:458-464.
253. Anonymous. 1997. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin. Exp. Immunol. 109(Suppl 1):1-28.
254. Gomez Morales MA, Ausiello CM, Guarino A, Urbani F, Spagnuolo MI, Pignata C, Pozio E. 1996. Severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report. Clin. Infect. Dis. 22:848-850.
255. Clifford CP, Crook DW, Conlon CP, Fraise AP, Day DG, Peto TE. 1990. Impact of waterborne outbreak of cryptosporidiosis on AIDS and renal transplant patients. Lancet 335:1455-1456.
256. Collier AC, Miller RA, Meyers JD. 1984. Cryptosporidiosis after marrow transplantation: person-to-person transmission and treatment with spiramycin. Ann. Intern. Med. 101:205-206.
257. Gentile G, Venditti M, Micozzi A, Caprioli A, Donelli G, Tirindelli C, Meloni G, Arcese W, Martino P. 1991. Cryptosporidiosis in patients with hematologic malignancies. Rev. Infect. Dis. 13:842-846.
258. McAnulty JM, Keene WE, Leland D, Hoesly F, Hinds B, Stevens G, Fleming DW. 2000. Contaminated drinking water in one town manifesting as an outbreak of cryptosporidiosis in another. Epidemiol. Infect. 125:79-86.
259. Hunter PR, Quigley C. 1998. Investigation of an outbreak of cryptosporidiosis associated with treated surface water finds limits to the value of case control studies. Commun. Dis. Public Health 1:234-238.
260. Chappell CL, Okhuysen PC, Sterling CR, Wang C, Jakubowski W, Dupont HL. 1999. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am. J. Trop. Med. Hyg. 60:157-164.
261. Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL. 1998. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect. Immun. 66:441-443.
262. Craun GF, Hubbs SA, Frost F, Calderon RL, Via SH. 1998. Waterborne outbreaks of cryptosporidiosis. J. Am. Water Works Assoc. 90:81-91.
263. Swift L, Hunter PR. 2004. What do negative associations between potential risk factors and illness in analytical epidemiological studies of infectious disease really mean? Eur. J. Epidemiol. 19:219-223.
264. Hunter PR, de Sylor MA, Risebro HL, Nichols GL, Kay D, Hartemann P. 2011. Quantitative microbial risk assessment of cryptosporidiosis and giardiasis from very small private water supplies. Risk Anal. 31:228-236.
265. Hunter PR, Zmirou-Navier D, Hartemann P. 2009. Estimating the impact on health of poor reliability of drinking water interventions in developing countries. Sci. Total Environ. 407:2621-2624.
266. Coutinho BP, Oria RB, Vieira CM, Sevilleja JE, Warren CA, Maciel JG, Thompson MR, Pinkerton RC, Lima AA, Guerrant RL. 2008. Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J. Parasitol. 94:1225-1232.
267. Mor SM, Tzipori S. 2008. Cryptosporidiosis in children in sub-Saharan Africa: a lingering challenge. Clin. Infect. Dis. 47:915-921.
268. Hunter P, Hughes S, Woodhouse S, Syed Q, Verlander NQ, Chalmers RM, Morgan K, Nichols G, Beeching N, Osborn K. 2004. Sporadic cryptosporidiosis case-control study with genotyping. Emerg. Infect. Dis. 10:1241-1249.
269. Elwin K, Hadfield SJ, Robinson G, Chalmers RM. 2012. The epidemiology of sporadic human infections with unusual cryptosporidia detected during routine typing in England and Wales, 2000-2008. Epidemiol. Infect. 140:673-683.
270. Van Valen L. 1973. A new evolutionary law. Evol. Theory 1:1-30.
271. Venditti C, Meade A, Pagel M. 2010. Phylogenies reveal new interpretation of speciation and the Red Queen. Nature 463:349-352.
272. Lively CM, Dybdahl MF. 2000. Parasite adaptation to locally common host genotypes. Nature 405:679-681.
273. Engelstadter J, Bonhoeffer S. 2009. Red Queen dynamics with nonstandard fitness interactions. PLoS Comput. Biol. 5:e1000469. doi:10.1371/journal.pcbi.1000469.
274. Ebert D. 1994. Virulence and local adaptation of a horizontally transmitted parasite. Science 265:1084-1086.
275. Anderson RM, May RM. 1982. Coevolution of hosts and parasites. Parasitology 85(Part 2):411-426.
276. Brubaker RR. 1985. Mechanisms of bacterial virulence. Annu. Rev. Microbiol. 39:21-50.
277. O'Hara SP, Yu JR, Lin JJ. 2004. A novel Cryptosporidium parvum antigen, CP2, preferentially associates with membranous structures. Parasitol. Res. 92:317-327.